Abrdn Life Sciences Investors Fund (HQL)
Abrdn Life Sciences Investors Fund (HQL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2017 | 09-2011 | 09-2007 | 09-2006 | |
| Sales | 0 | 0 | 2,870 | 2,300 |
| Gross Profit | N/A | N/A | 2,870 | 2,300 |
| Operating Expenses | 0 | 0 | 4,220 | 3,400 |
| Operating Income | N/A | N/A | -1,350 | -1,100 |
| Other Income | 0 | 0 | -360 | -230 |
| Pre-tax Income | 0 | 0 | -1,710 | -1,330 |
| Net Income Continuous | N/A | N/A | -1,710 | -1,330 |
| Net Income | $N/A | $N/A | $-1,710 | $-1,330 |
| EPS Basic Total Ops | N/A | N/A | -0.10 | -0.10 |
| EPS Basic Continuous Ops | N/A | N/A | -0.10 | -0.10 |
| EBITDA(a) | $N/A | $N/A | $-1,350 | $-1,100 |